
Fresenius SE (FSNUY) announced its intention to sell 13.4M shares in Fresenius Medical Care (FMS) through a placing to institutional investors by way of an accelerated bookbuild offering. The placing
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| FMS | Fresenius Medical Care | 20.95 | -0.46 | -2.17% |
| Name | Price | % Change | |
|---|---|---|---|
| $20.95 | -2.17% |

Fresenius SE (FSNUY) announced its intention to sell 13.4M shares in Fresenius Medical Care (FMS) through a placing to institutional investors by way of an accelerated bookbuild offering. The placing

Fresenius Medical Care ( ($FMS) ) has issued an announcement. Fresenius Medical Care is the world’s leading provider of products and services for people with renal diseases, including dialysis treatments

Barclays downgraded Fresenius Medical (FMS) to Underweight from Equal Weight with a price target of EUR 35, down from EUR 44.50. The firm cites its “increasing concerns” over the company’s

In a report released today, Anna Ractliffe from Bank of America Securities reiterated a Sell rating on Fresenius Medical Care AG & Co. KGaA, with a price target of €32.00.

Fresenius Medical Care (($FMS)) has held its Q3 earnings call. Read on for the main highlights of the call. Fresenius Medical Care’s earnings call delivered a mixed but generally constructive

Fresenius Medical Care ( ($FMS) ) has provided an update. On November 3, 2026, Fresenius Medical Care reported financial condition and operating results for the three and nine months ended

An update from Fresenius Medical Care ( ($FMS) ) is now available. Fresenius Medical Care is a global provider of kidney-care products and services, including dialysis treatment, equipment and related

Fresenius Medical Care (FMS) is scheduled to report 3rd quarter earnings on 11/03/2026. Regarding Q3 estimates, Wall Street analysts expect Fresenius Medical Care to post earnings of $0.65 per share.

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily

After HHS published a new Kidney Care National Plan, JPMorgan said bears will focus on the strong rhetoric around the large incumbent providers, Fresenius Medical (FMS) and DaVita (DVA), and
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 23, 2027TBA | $11.60B | $0.54 | $5.59B | 0.14 | 13.28 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.